Stamatia Papoutsopoulou

17PUBLICATIONS
73CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Central nervous systemMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 28, 2026
Novel 3-Amino-2-methylquinazolinone NF-κB Inhibitors: Synthesis and Potential Anti-Inflammatory Function.

|Feb 27, 2026
Association Between Caffeine Levels and Symptom Profile in Schizophrenia: Results from a Cohort Study in Central Greece.

Michel B Janho, Maria N Papaliaga, Athina A Samara

|Oct 20, 2025
"Recommendations for clinical study protocols for immune and inflammatory profiling in Parkinson's disease".

Laura Muñoz-Delgado, Caroline H Williams-Gray, Gaetan Garraux

|Nov 27, 2024
A Novel Quinoline Inhibitor of the Canonical NF-κB Transcription Factor Pathway.

Panagiotis Ntavaroukas, Konstantinos Michail, Rafaela Tsiakalidou

|Sep 28, 2024
Erythropoietin Reduces Inflammation, Oxidative Stress, and Apoptosis in a Rat Model of Bleomycin-Induced Idiopathic Pulmonary Fibrosis.

Drosos Tsavlis, Kalliopi Domvri, Konstantinos Porpodis

|Apr 27, 2024
Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson's Disease.

Jasna Saponjic, Rebeca Mejías, Neda Nikolovski

Pageof 3

Frequent Collaborators

5 joint publications

Barry J Campbell

3 joint publications

Matthaios Speletas

2 joint publications

Katie Lloyd

2 joint publications

Cristoforo Comi